Σελίδες

▼

Παρασκευή 29 Ιουλίου 2022

Centers for Disease Control and Prevention ,update

Centers for Disease Control and Prevention 

Prevention of disease, disability, and death through immunization and by control of respiratory and related diseases.

  

The following materials have been updated to reflect the latest ACIP recommendation.

  • Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Moderna COVID-19 Vaccine for Children Aged 6–11 Years
  • Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Moderna COVID-19 Vaccine for Persons Aged 12-17 Years
  • ACIP Evidence to Recommendations for Use of Moderna COVID-19 Vaccine in Children Ages 6 – 11 years and Adolescents Ages 12 – 17 years under an Emergency Use Authorization
 
View Now